Opioid-Free Combined Anesthesia With Spontaneous Breathing for VATS
Summary
Non-tracheal intubated combined anesthesia with preserved spontaneous breathing significantly enhances the quality and speed of recovery post-VATS for patients undergoing lung nodule surgery. The "opioid-sparing strategy," which substitutes ketamine for opioids during surgery, not only provides effective analgesia but also protects perioperative lung function and reasonably prevents the occurrence of opioid-related adverse reactions; it also reduces medical costs and shortens the average hospital stay. However, the degree of benefit to patients lacks high-level clinical evidence. This study aims to comprehensively assess the effect of opioid-free combined anesthesia with preserved spontaneous breathing for VATS lung nodule surgery on postoperative rapid recovery from multiple aspects including postoperative lung function and pulmonary complications, pain, gastrointestinal function, nausea/vomiting, cognitive function, and depression/anxiety, intending to expand the dataset and application prospects in this field, and increase feasibility experience.
Timeline
- Start
- 2024-10-01
- Primary completion
- 2026-07-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Esketamine | Other / unclassified | 0.5 mg/kg | Intravenous |
| Background | Remifentanil | Small molecule | 0.01 ug/kg | Intravenous |
| Background | Remifentanil | Small molecule | 0.1 ug/kg | Intravenous |
| Background | Sufentanil | Other / unclassified | 0.1 ug/kg | Intravenous |
| Background | Sufentanil | Other / unclassified | 0.5 ug/kg | Intravenous |
Indications
No indication recorded.